These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 23286786)

  • 1. Intrahippocampal injection of Aβ1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain.
    Zheng M; Liu J; Ruan Z; Tian S; Ma Y; Zhu J; Li G
    Amyloid; 2013 Mar; 20(1):13-20. PubMed ID: 23286786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer's Disease Model.
    Oh SH; Kim HN; Park HJ; Shin JY; Lee PH
    Cell Transplant; 2015; 24(6):1097-109. PubMed ID: 24612635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early changes in hyppocampal neurogenesis induced by soluble Ab1-42 oligomers].
    Komleva YK; Lopatina OL; Gorina YV; Chernykh AI; Shuvaev AN; Salmina AB
    Biomed Khim; 2018 Aug; 64(4):326-333. PubMed ID: 30135279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
    Moon M; Cha MY; Mook-Jung I
    J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.
    Gao HL; Li C; Nabeka H; Shimokawa T; Wang ZY; Cao YM; Matsuda S
    J Alzheimers Dis; 2016 Jun; 53(3):1173-92. PubMed ID: 27372641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Estradiol Administration During the Early Stage of Alzheimer's Disease Pathology Rescues Adult Hippocampal Neurogenesis and Ameliorates Cognitive Deficits in Aβ
    Zheng JY; Liang KS; Wang XJ; Zhou XY; Sun J; Zhou SN
    Mol Neurobiol; 2017 Dec; 54(10):7656-7669. PubMed ID: 27838872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembling nanofibers improve cognitive impairment in a transgenic mice model of Alzheimer's disease.
    Yang H; Qu T; Yang H; Wei L; Xie Z; Wang P; Bi J
    Neurosci Lett; 2013 Nov; 556():63-8. PubMed ID: 24103374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited hippocampal neurogenesis in SAMP8 mouse model of Alzheimer's disease.
    Gang B; Yue C; Han N; Xue H; Li B; Sun L; Li X; Zhao Q
    Brain Res; 2011 May; 1389():183-93. PubMed ID: 21439270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Abeta production by NF-kappaB inhibitors.
    Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
    Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomers of β-amyloid protein (Aβ1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1β, tumour necrosis factor-α, and a nuclear factor κ-B mechanism in the rat brain.
    Carrero I; Gonzalo MR; Martin B; Sanz-Anquela JM; Arévalo-Serrano J; Gonzalo-Ruiz A
    Exp Neurol; 2012 Aug; 236(2):215-27. PubMed ID: 22617488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo.
    Tang SS; Hong H; Chen L; Mei ZL; Ji MJ; Xiang GQ; Li N; Ji H
    Neurobiol Aging; 2014 Mar; 35(3):590-9. PubMed ID: 24269024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble oligomers and fibrillar species of amyloid β-peptide differentially affect cognitive functions and hippocampal inflammatory response.
    He Y; Zheng MM; Ma Y; Han XJ; Ma XQ; Qu CQ; Du YF
    Biochem Biophys Res Commun; 2012 Dec; 429(3-4):125-30. PubMed ID: 23146634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
    Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
    J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
    Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
    Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease.
    Mirochnic S; Wolf S; Staufenbiel M; Kempermann G
    Hippocampus; 2009 Oct; 19(10):1008-18. PubMed ID: 19219917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β induces cyclooxygenase-2 and PGE2 release in human astrocytes in NF-κ B dependent manner.
    Blanco A; Alvarez S; Fresno M; Muñoz-Fernández MÁ
    J Alzheimers Dis; 2010; 22(2):493-505. PubMed ID: 20847443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
    J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity.
    Kärkkäinen V; Pomeshchik Y; Savchenko E; Dhungana H; Kurronen A; Lehtonen S; Naumenko N; Tavi P; Levonen AL; Yamamoto M; Malm T; Magga J; Kanninen KM; Koistinaho J
    Stem Cells; 2014 Jul; 32(7):1904-16. PubMed ID: 24753106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
    Meunier J; Villard V; Givalois L; Maurice T
    Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.